Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry.
Saved in:
| Title: | Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry. |
|---|---|
| Authors: | Switzer C; Global Pharmacovigilance and Epidemiology, Sanofi Pasteur, Toronto, Ontario, Canada., Tikhonov I; Global Pharmacovigilance and Epidemiology, Sanofi Pasteur, Swiftwater, Pennsylvania, USA., Khromava A; Epidemiology and Benefit-Risk, Sanofi Pasteur, Toronto, Ontario, Canada., Pool V; Medical Affairs, Sanofi Pasteur, Swiftwater, PA, USA., Lévesque LE; Epidemiology and Benefit-Risk, Sanofi Pasteur, Toronto, Ontario, Canada. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Dec 02; Vol. 17 (12), pp. 5325-5333. Date of Electronic Publication: 2021 Dec 29. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
